TOXOPLASMA DEVELOPMENT AND CELL CYCLE
TOXOPLASMA DEVELOPMENT AND CELL CYCLE
批准号:
2886106
负责人:
Kami Kim
金额:
$6.97万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2003-03-31
关键词:
Toxoplasma gondii biological signal transduction cell cycle cyclin dependent kinase cytogenetics flow cytometry gene expression genetic mapping genetic regulation genetic regulatory element immunofluorescence technique laboratory mouse laboratory rabbit microorganism genetics northern blottings nucleic acid sequence protozoal infection ribonucleotide reductase transfection western blottings
中文摘要
描述(改编自申请人的摘要):专有的细胞内
弓形虫寄生虫是一种重要的条件致病菌。
免疫功能受损的个人,如艾滋病患者。弓形虫还会导致
对新生儿造成毁灭性的出生缺陷。这些研究旨在
进一步了解弓形虫的致病机制
在其人类宿主内持续存在并引起疾病。工资支持
由K02奖提供的将使Kim博士有“保护时间”
专注于她努力采用其他公司的技术和专业知识
生物学研究领域,特别是真核细胞周期
对细胞周期和信号转导的研究
弓形虫发育。在人类宿主中,弓形虫以
速殖子,这是导致临床上明显疾病的原因,以及AS
缓殖子,这是一种潜在的囊状形式。随着免疫功能的减弱,
生长缓慢的缓殖子可以重新激活到快速增殖的
速殖子形成,导致弓形虫脑炎。考虑到被标记的
速殖子和缓殖子在增殖方面的差异
弓形虫不能在宿主细胞外复制,细胞周期
监管无疑是弓形虫发展和发展的关键
疾病的发病机制。从对其他真核生物的研究中可以清楚地看到,
对发育或分化信号的反应发生在特定的
细胞周期内的点,并导致坐标调制
阶段特异性基因表达与细胞周期进程。候选人
假设弓形虫细胞周期调控的独特方面
协调导致疾病发病机制和细胞内的过程
生死存亡。目的1:弓形虫细胞周期基因表达的调控
将重点分析核糖核苷酸还原酶(RNR)基因的表达。
目的2:弓形虫细胞周期蛋白依赖性蛋白激酶的表达和功能
(CDK)将使用免疫荧光、流式细胞术、Northern
和Western blotting。带有突变CDK的构建物将被转染到
速殖子以确定CDKs在细胞周期进程中的作用。
最后,在目标3中,
细胞周期调控与弓形虫缓殖子发育的关系
将会被研究。细胞周期标志物将被用来检查细胞周期
对缓殖子发育的依赖性。细胞周期与缓殖子报告
构建将被用来测试细胞周期抑制剂和
基因表达分化的潜在诱导剂或抑制物。
这些将是长期努力的初步实验,目的是定义
细胞周期调控在弓形虫速殖子-缓殖子中的作用
分化和致病力。
英文摘要
DESCRIPTION (adapted from applicant's abstract): The obligate intracellular
parasite Toxoplasma gondii is an important opportunistic pathogen in
immunocompromised individuals such as AIDS patients. T. gondii also causes
devastating birth defects in neonates. These studies are designed to
provide further understanding of the mechanisms by which T. gondii is able
to persist and cause disease within its human host. The salary support
provided by the K02 award will enable Dr. Kim to have "protected time" to
concentrate upon her efforts to adapt technology and expertise from other
areas of biological investigation, specifically eukaryotic cell cycle
regulation and signal transduction, to the study of cell cycle and
Toxoplasma development. Within human hosts, T. gondii exists as
tachyzoites, which are responsible for clinically apparent disease, and as
bradyzoites, which are latent encysted forms. With waning immune function,
slow-growing bradyzoites can reactivate to the rapidly proliferating
tachyzoite forms, leading to Toxoplasma encephalitis. Given the marked
difference in proliferation of the tachyzoite compared to the bradyzoite and
Toxoplasma's inability to replicate outside host cells, cell cycle
regulation is undoubtedly critical in Toxoplasma development and
pathogenesis of disease. It is clear from studies of other eukaryotes that
responses to signals for development or differentiation occur at specific
points within the cell cycle and result in a coordinate modulation of
stage-specific gene expression and cell cycle progression. The candidate
hypothesizes that unique aspects of T. gondii cell cycle regulation
coordinate the processes leading to disease pathogenesis and intracellular
survival. In Aim 1, regulation of cell cycle gene expression in T. gondii
will be analyzed focusing on ribonucleotide reductase (RNR) gene expression.
In Aim 2, expression and function of T. gondii cyclin dependent kinases
(cdk) will be examined using immunofluorescence, flow cytometry, Northern
and Western blotting. Constructs with mutant cdks will be transfected into
tachyzoites to determine the role of cdks in cell cycle progression.
Finally, in Aim 3, the
relationship of cell cycle regulation and T. gondii bradyzoite development
will be studied. Cell cycle markers will be used to examine the cell cycle
dependence of bradyzoite development. Cell cycle and bradyzoite reporter
constructs will be used to test the effects of cell cycle inhibitors and
potential inducers or inhibitors of differentiation on gene expression.
These will be the initial experiments in a long-term effort to define the
role of cell cycle regulation in Toxoplasma tachyzoite-bradyzoite
differentiation and virulence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the roles of protein O-GlcNAcylation in Toxoplasma gondii
-
批准号:8512340
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2013
-
负责人:Kami Kim
-
依托单位:
Dissecting the roles of protein O-GlcNAcylation in Toxoplasma gondii
-
批准号:8719923
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2013
-
负责人:Kami Kim
-
依托单位:
IVIS Spectrum imager of bioluminescence and fluorescence
-
批准号:7795614
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Toxoplasma Epigenomics and Gene Expression
-
批准号:8220901
-
项目类别:
-
资助金额:$72.23万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Toxoplasma Epigenomics and Gene Expression
-
批准号:9132480
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Toxoplasma Epigenomics and Gene Expression
-
批准号:8613429
-
项目类别:
-
资助金额:$65.51万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Toxoplasma Epigenomics and Gene Expression
-
批准号:7950538
-
项目类别:
-
资助金额:$64.28万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Toxoplasma Epigenomics and Gene Expression
-
批准号:8432851
-
项目类别:
-
资助金额:$67.9万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
A Systems Biology Approach to the Model Apicomplexan Toxoplasma gondii
-
批准号:8048844
-
项目类别:
-
资助金额:$563.02万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Toxoplasma Epigenomics and Gene Expression
-
批准号:8039979
-
项目类别:
-
资助金额:$72.66万
-
财政年份:2010
-
负责人:Kami Kim
-
依托单位:
Geographic Medicine and Emerging Infections
-
批准号:8742423
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2008
-
负责人:Kami Kim
-
依托单位:
Differentiation and Signaling in Toxoplasmosis
-
批准号:6897808
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2004
-
负责人:Kami Kim
-
依托单位:
Differentiation and Signaling in Toxoplasmosis
-
批准号:6843280
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2004
-
负责人:Kami Kim
-
依托单位:
Differentiation and Signaling in Toxoplasmosis
-
批准号:7071700
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2004
-
负责人:Kami Kim
-
依托单位:
Differentiation and Signaling in Toxoplasmosis
-
批准号:7415188
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2004
-
负责人:Kami Kim
-
依托单位:
Differentiation and Signaling in Toxoplasmosis
-
批准号:7237990
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2004
-
负责人:Kami Kim
-
依托单位:
7th International Congress on Toxoplasmosis
-
批准号:6599359
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2003
-
负责人:Kami Kim
-
依托单位:
Purine salvage as a chemotherapeutic target in malaria
-
批准号:6535755
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2002
-
负责人:Kami Kim
-
依托单位:
SERINE PROTEINASES IN APICOMPLEXAN PARASITES
-
批准号:6215457
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2000
-
负责人:Kami Kim
-
依托单位:
SERINE PROTEINASES IN APICOMPLEXAN PARASITES
-
批准号:6534232
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2000
-
负责人:Kami Kim
-
依托单位:
海外基金